V-0709 |
Neuroendocrine Regulatory Peptide-2 (human), NERP-2 (human) |
C173H288N56O57 |
4064.53 |
|
Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Gly-Leu-Gly-NH2 |
V-0710 |
Neuroendocrine Regulatory Peptide-2 (rat), NERP-2 (rat) |
C175H290N56O59 |
4122.57 |
|
Pyr-Ala-Glu-Ala-Thr-Arg-Gln-Ala-Ala-Ala-Gln-Glu-Glu-Arg-Leu-Ala-Asp-Leu-Ala-Ser-Asp-Leu-Leu-Leu-Gln-Tyr-Leu-Leu-Gln-Gly-Gly-Ala-Arg-Gln-Arg-Asp-Leu-Gly-NH2 |
V-0711 |
TLQP-21 (human) |
C110H176N40O27 |
2490.86 |
1259837-37-0 |
H-Thr-Leu-Gln-Pro-Pro-Ser-Ala-Leu-Arg-Arg-Arg-His-Tyr-His-His-Ala-Leu-Pro-Pro-Ser-Arg-OH |
V-0712 |
TLQP-21 (mouse, rat) |
C107H170N40O26 |
2432.78 |
869988-94-3 |
H-Thr-Leu-Gln-Pro-Pro-Ala-Ser-Ser-Arg-Arg-Arg-His-Phe-His-His-Ala-Leu-Pro-Pro-Ala-Arg-OH |
W-0101 |
WWamide-1 |
C46H65N11O10S |
964.16 |
149665-72-5 |
H-Trp-Lys-Glu-Met-Ser-Val-Trp-NH2 |
W-0102 |
WWamide-2 |
C46H65N13O10S |
992.17 |
149636-88-4 |
H-Trp-Arg-Glu-Met-Ser-Val-Trp-NH2 |
W-0103 |
WWamide-3 |
C46H66N12O9S |
963.17 |
149636-89-5 |
H-Trp-Lys-Gln-Met-Ser-Val-Trp-NH2 |
W-0104 |
WKYMVMamide |
C41H61N9O7S2 |
856.12 |
187986-11-4 |
H-Trp-Lys-Tyr-Met-Val-Met-NH2 |
W-0105 |
WKYMVmamide, W-Peptide |
C41H61N9O7S2 |
856.12 |
187986-17-0 |
H-Trp-Lys-Tyr-Met-Val-D-Met-NH2 |
X-0101 |
Xenopsin (XP) |
C47H73N13O10 |
980.18 |
51827-01-1 |
Pyr-Gly-Lys-Arg-Pro-Trp-Ile-Leu-OH |
X-0102 |
Xenopsin-Related Peptide 1 (XP-1), Xenin-8 (human) |
C51H79N15O9 |
1046.28 |
117442-28-1 |
H-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu-OH |
X-0103 |
Xenopsin-Related Peptide 2 (XP-2) |
C60H88N16O10 |
1193.46 |
117442-29-2 |
H-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu-OH |
X-0104 |
Xenin 25 |
C139H224N38O32S |
2971.61 |
144092-28-4 |
H-Met-Leu-Thr-Lys-Phe-Glu-Thr-Lys-Ser-Ala-Arg-Val-Lys-Gly-Leu-Ser-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu-OH |
Y-0101 |
|
C32H50N8O7 |
658.8 |
121305-29-1 |
H-His-Leu-Pro-Pro-Pro-Val-OH |
Y-0102 |
|
C64H98N16O13 |
1299.58 |
154244-49-2 |
H-His-Leu-Pro-Pro-Pro-Val-His-Leu-Pro-Pro-Pro-Val-OH |